Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults

Author:

Chen Kang1ORCID,Shen Zewei2,Gu Weijun1,Lyu Zhaohui1,Qi Xuan3ORCID,Mu Yiming1ORCID,Ning Yi4,

Affiliation:

1. Department of Endocrinology First Medical Center of Chinese PLA General Hospital Beijing China

2. Biostatistics and Data Science Novo Nordisk (China) Pharmaceuticals Co., Ltd Beijing China

3. Medical Affairs Novo Nordisk (China) Pharmaceuticals Co., Ltd Beijing China

4. Meinian Institute of Health Beijing China

Abstract

AbstractAimTo evaluate the prevalence of overweight/obesity and associated complications from a large, cross‐sectional, nationwide database in China.Materials and MethodsData were obtained from 519 Meinian health check‐up centres across 243 cities. Eligible participants were aged ≥18 years, with a routine check‐up in 2019 (N = 21 771 683) and complete height, weight, sex and region data. The unadjusted prevalence rates of overweight/obesity were calculated by age, sex and region. In addition, the nationwide prevalence rates of overweight and obesity were standardized according to the 2010 China census by age group and sex. The prevalence of obesity‐related complications by body mass index (BMI) groups was calculated using logistic regression.ResultsThere were 15 770 094 eligible participants (median age 40 years; mean BMI 24.1 kg/m2; 52.8% male). By Chinese BMI classification, 34.8% were overweight and 14.1% were obese. Overweight and obesity were more prevalent in male than female participants (standardized: overweight 40.2% vs. 27.4%; obesity 17.6% vs. 9.6%, respectively). The prevalence of assessed complications was higher in participants with overweight/obesity versus those with normal BMI (P < 0.001 for trends). The most prevalent complications in participants with overweight/obesity were fatty liver disease, prediabetes, dyslipidaemia and hypertension. The number of complications increased with higher BMI.ConclusionsOverweight/obesity and related complications are highly prevalent in this population. These data may better inform management and prevention public health strategies in China.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3